Correlation of Aortic Versus Pulmonary ITV in Response to Vascular Filling
NCT ID: NCT04899323
Last Updated: 2023-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2021-07-21
2023-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For each patient admitted to an emergency department with a sepsis syndrome requiring vascular filling, the pulmonary ITV and the aortic ITV were measured at each phase of vascular filling.
This is a non-interventional study, the management of patients will not differ from usual practices and vascular filling should not be delayed in any case. Emergency doctors who are already experts in ultrasound, monitoring vascular filling by measuring the aortic ITV, will have to measure the pulmonary ITV after each filling of 250cc of Ringer's Lactate in 10 minutes with a limited amount of time.
The evolution of ITV measurements and vital parameters should be recorded for each patient.
In order to ensure quality, the emergency doctors will first receive a short training (presentation of the study and review of the measurements requested). In addition, measurement records will be analyzed at random.
At the end of this study, the correlation between the variation of the aortic and pulmonary ITV could be compared. The objective would be to promote the monitoring of these unstable patients via the pulmonary ITV. This measurement would be easier to perform than the aortic ITV, which is currently only performed by emergency doctors who are experts in hemodynamic ultrasound.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transpulmonary Thermodilution and Transesophageal Echocardiography in Early Septic Shock
NCT01188993
Carotid Ultrasounds Measurements in Septic Shock
NCT05444621
Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
NCT04870892
Strain Echocardiography During Septic Shock : an Observational Pilot Study
NCT03663192
Ultrasound Optimization of Initial Fluid Challenge in Sepsis
NCT04028102
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
Perform a 250cc vascular filling over 10 minutes and then perform a cardiac ultrasound. Repeat the vascular filling followed by the ultrasound as long as the patient is responsive.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with suspected infectious syndrome
* qSOFA \>= 2
* Tachycardia\>120 and/or PAS \< 100mm Hg / MAP \<60 mmHg
Exclusion Criteria
* Vascular filling \> 500 ml before hemodynamic evaluation by echo cardiography
* Perfusion of catecholamine (norepinephrine, epinephrine, or dobutamine) at the time of inclusion in the study (before hemodynamic assessment by echo cardiography)
* Patient sedated and on positive pressure ventilation, including NIV
* Tamponade due to a compressive pericardial or pleural effusion
* Patient with known pre-capillary PAH \> 50 mmHg PAPS
* Presence of suspected acute valvulopathy requiring immediate cardiological expertise
* Absence of an acoustic window allowing the evaluation of the aortic or pulmonary ITV
* Minor patients, adults under guardianship, protected persons
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nantes University Hospital
Nantes, Loire-Atlantique, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC21_0026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.